Rybelsus Savings Card 2026: What It Pays Now, Who Qualifies, and the Ozempic Tablet Transition

Disclosure: Some links on this page are affiliate links. If you use one of those links, we may earn compensation at no extra cost to you. We do not earn compensation from official Novo Nordisk, Rybelsus, or NovoCare links — and those are the links most readers on this page will need.

---

By The RX Index Editorial Team · Last verified: August 3, 2026 · Next re-verification: August 31, 2026

Educational use only — not medical advice.

---

Bottom line

The Rybelsus savings card lets eligible people with commercial insurance that covers Rybelsus pay as little as $25 per fill. But as of January 2, 2026, the card pays a maximum of $100 on a one-month fill — down from $300. So a $250 copay leaves you paying $150, not $25. Medicare, Medicaid, VA, TRICARE, and uninsured patients cannot use it.

Here's the part the savings-card answer cannot ignore: Novo Nordisk is discontinuing all strengths of Rybelsus. The company told Illinois Medicaid that wholesaler shipments would cease beginning in May 2026 and existing inventory was expected to become limited starting in July. Ozempic tablets are the planned transition product for maintenance treatment — the same active ingredient in a better-absorbed formulation, with lower milligram strengths and a separate manufacturer self-pay offer. A prescriber must direct the switch.

That cash price changes the math for a lot of people. We'll show you exactly where the line falls.

✓ Get the current official Rybelsus Savings Offer →    See what you'll actually pay →

Sources: current Rybelsus Savings Offer, printable offer terms, and Illinois HFS transition notice.

---

Which path applies to you

Rybelsus savings card quick-decision guide by insurance type

---

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

The right GLP-1 provider isn't the same for everyone — it depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred treatment path (injection or oral), and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to get a personalized provider match with source-verified pricing before you choose.

Already on Rybelsus for type 2 diabetes and you just want the cost answer? Keep reading. The tool is built for people choosing a treatment path, not people who already have one.

---

Jump to your situation

1. Is the Rybelsus savings card still active in 2026?
2. How much does it actually save you?
3. Who qualifies — and three plans people wrongly think are excluded
4. How to get the card and use it at the pharmacy
5. Why your card isn't working
6. Is Rybelsus being discontinued?
7. How do Rybelsus and Ozempic tablet strengths line up?
8. The cheaper path most people miss
9. If you don't have insurance
10. If you have Medicare, Medicaid, VA, or TRICARE
11. Can you use the card for a 90-day supply?
12. Can you stack it with GoodRx or SingleCare?
13. “I'm taking this for weight loss” — the honest reroute
14. What we actually verified
15. Frequently asked questions

---

Is the Rybelsus savings card still active in 2026?

Yes. Novo Nordisk's current Rybelsus savings card says eligible patients with commercial insurance that covers Rybelsus may pay as little as $25 for a one-, two-, or three-month prescription. The offer covers a maximum of $100 per one-month fill, $200 per two-month fill, and $300 per three-month fill. Activation lasts up to 48 months from enrollment.

The card is real and it's free. But the terms changed on January 2, 2026, and that change is the reason a lot of people think the card broke.

Current Rybelsus savings offer terms, verified August 3, 2026

Source: NovoCare Diabetes Savings Offer Program terms and the printable Rybelsus Savings Offer, checked August 3, 2026.

Provider-stated vs. verified

The exact claims a reader is likely to act on, traced to the current source that controls them

Why one official page still says $10

You are not imagining it. An official Rybelsus Resources page still displays the old $10 amount, while the active savings page and dated 2026 terms say $25.

What Novo Nordisk's own pages said about the Rybelsus savings amount, checked August 3, 2026

Use $25. The current dated terms and generated card are the materials the pharmacy claim is supposed to follow. If you saw $10 on the Resources page, you found an official page that has not caught up with the January 2026 offer.

Micro-step: Before you read another word, do one thing — get a fresh card. A newly generated offer gives you the current terms and the full identifiers the pharmacy needs. The offer is limited to one person and is not transferable, so never use an offer generated for someone else. ✓ Get the current official Rybelsus Savings Offer → Official Novo Nordisk link. Not sponsored. We earn nothing if you use it.

---

How much does the Rybelsus savings card actually save you?

The card pays up to $100 on a one-month fill, so your estimated cost is your insurance-processed amount minus up to $100, with a $25 floor unless your amount was already lower. A $75 amount becomes $25. A $400 amount becomes $300. The $25 headline reaches people whose pre-card responsibility is $125 or less.

The one thing we'd want you to know before you walk into the pharmacy

Here it is, said plainly, because you deserve it before you get to the counter:

The Rybelsus savings card does not cover your whole bill, and in January it got a lot smaller. The maximum it pays dropped from $300 a month to $100 a month. If your plan leaves you owing the same $400, you used to pay $100. You now pay $300. That is $2,400 more a year for the exact same pill.

That's a real cut and we're not going to dress it up.

But read the next part, because it's the useful half.

If what you need is one flat, predictable price every month no matter what your plan does, the savings card can't give you that — a self-pay offer can, and there is now a separate self-pay price on Ozempic tablets. But the Rybelsus card runs behind your commercial insurance, and Novo Nordisk says it intends the savings to be credited toward your out-of-pocket obligations. An accumulator or maximizer can prevent that credit, while an Ozempic tablet self-pay purchase is explicitly outside insurance and cannot count toward a deductible or out-of-pocket limit. That's the whole trade, and which side wins depends on numbers we're about to hand you.

What you'll pay, by pre-card amount

Rybelsus savings card real-cost examples, one-month fill

The one-month formula is simple:

estimated final amount = min(pre-card amount, max($25, pre-card amount − $100))

$125 is the line. At or under it, you reach $25 unless your original amount was already lower. Over it, you pay the difference after the $100 cap.

What the January change cost you

Rybelsus savings offer, before and after January 2, 2026

Run that against a real pre-card amount and the size of the change shows up fast.

What the same person pays before and after the change, assuming the plan leaves the same amount and all terms are met

Historical terms source: Novo Nordisk's Rybelsus Connect terms showing the former $10 floor and $300/$600/$900 caps. Current terms source: NovoCare Diabetes Savings Offer Program.

### Rybelsus cost calculator Enter your strength, insurance type, days supply, whether your plan covers Rybelsus, and the amount the processed claim leaves you owing. We'll show you the card estimate, the cap arithmetic, and — for a label-supported maintenance transition your prescriber approves — the current Ozempic tablet self-pay comparison. No email. No account. Nothing leaves your browser. → Calculate my Rybelsus cost Estimate only. Your plan's adjudicated claim, the program's current terms, and pharmacy processing determine the final number.

---

Who qualifies for the Rybelsus savings card?

You may qualify if you live in the U.S. or its territories, have commercial or private insurance that covers Rybelsus, process the prescription through that plan, and hold a valid prescription with a prescriber ID. You do not qualify if you have Medicare, Medicaid, VA, DoD, TRICARE, certain government-subsidized retiree drug coverage, or no insurance. Paying cash to bypass an excluded plan does not create eligibility.

The four questions, in order

Walk these in order. The first “no” tells you the card isn't your path — and every “no” has a section below with a real alternative.

1. Do you live in the U.S. or a U.S. territory?
2. Do you have commercial or private insurance? Not Medicare, Medicaid, VA, DoD, TRICARE, or another excluded government program.
3. Does that plan cover Rybelsus? This is the one people skip. “Covered” means the plan processes Rybelsus under the pharmacy benefit — the list of drugs a plan covers is called a formulary.
4. Do you have a valid prescription with a prescriber ID?

Three plans people wrongly assume are excluded

This is buried in Novo Nordisk's current eligibility terms: these plans are not automatically treated as government programs for this offer:

• FEHB — the Federal Employees Health Benefits Program
• ACA Marketplace plans — health exchange coverage
• State employee plans

If you're on one of these, the plan type alone does not block you. You still have to meet everything else — your plan still has to cover Rybelsus, the claim has to run through insurance, and every other offer term applies.

Rybelsus savings card eligibility by insurance type

The copay accumulator trap

This one is quiet and it costs people real money.

Some employer plans run a copay accumulator — manufacturer assistance does not count toward your deductible or other out-of-pocket amounts. Others run a copay maximizer — cost sharing is adjusted around the available manufacturer benefit.

Novo Nordisk's terms are direct about this: except where prohibited by law, if your plan uses either type of program, you are not eligible for the offer, and Novo Nordisk reserves the right to reduce or discontinue your assistance. The terms also require you to stop using the offer and inform Novo Nordisk if you learn that one applies.

The offer terms acknowledge that you may be unaware whether your plan does this.

Here's how to find out. Call HR, your benefits administrator, or the pharmacy-benefit number on your card and ask exactly this:

“Does our plan use a copay accumulator, a copay maximizer, or an alternate-funding arrangement that affects manufacturer assistance?”

If the answer is yes, the card may be blocked by the plan terms — not by the pharmacist. Skip to the self-pay comparison, but compare it only if your prescriber says an Ozempic tablet transition is appropriate.

One more state-level detail

Massachusetts: whether the offer is available depends on state law in effect when you present it. If you're in Massachusetts and the card is refused, call 1-877-304-6855 before you assume the pharmacy made a mistake.

Cleared all four questions and none of the traps apply? That's the eligibility lane the published terms describe. The card is free and there is no membership fee. ✓ Check your eligibility and get the card at Rybelsus.com → Not sure your plan covers Rybelsus? Call the pharmacy-benefit number on the back of your insurance card and ask: “Is Rybelsus covered for this prescription, what tier is it, and does it require prior authorization or step therapy?” Prior authorization means the plan wants clinical information before it decides whether to cover the claim.

---

How to get the Rybelsus savings card and use it at the pharmacy

Enroll at Rybelsus.com or text READY to 21848 to get a current offer. At the pharmacy, your commercial insurance must be billed first and the Rybelsus savings card submitted second as a copay-only secondary claim. Prescriptions filled before you enroll cannot be reimbursed.

The order matters more than anything else on this page. Insurance first. Card second. That's it.

Six steps

1. Confirm your plan covers Rybelsus. If it doesn't, the card has no covered claim to reduce.
2. Enroll at Rybelsus.com, or text READY to 21848. Message and data rates may apply.
3. Save the current card to your phone and print a backup. Use every identifier shown on your generated offer; never use another person's card, group number, or member ID.
4. Bring four things: your prescription, your insurance card, your savings offer, and a backup payment method.
5. Tell the pharmacist to bill your insurance first, then run the offer as secondary.
6. Check the price before you pay. If it's not what you expected, use the rejection decoder below.

What the pharmacy needs

The current processing details are:

Rybelsus savings offer pharmacy processing details, verified August 3, 2026

We checked the current card output and the current NovoCare pharmacist instructions. Never copy a group or member ID from a blog, screenshot, or another person's offer.

Copy this and hand it to the pharmacist

“Could you please run my commercial prescription insurance first, then process the Rybelsus manufacturer savings offer as a secondary, copay-only claim using every identifier on my card? The current Rybelsus instructions use BIN 019158 and other coverage code 08. If it won't go through, the pharmacist help desk is 1-844-373-0987.”

And this one for your insurance company

“Is Rybelsus covered under my pharmacy benefit for this prescription? Does it require prior authorization or step therapy? And does my plan use a copay accumulator, maximizer, or alternate-funding arrangement that affects manufacturer assistance?”

If you use mail order

If your mail-order pharmacy cannot process the card directly, the current offer includes a paper reimbursement path when you fill through mail order or cannot have the offer processed locally.

Send the completed form from NovoReimburse.com, a copy of your savings offer with the group and member numbers, the original pharmacy receipt, and a legible copy of the front and back of your primary prescription insurance card to:

Novo Nordisk Savings Offer Claims Processing Dept. PO Box 2355 Morristown, NJ 07962

Allow six to eight weeks. Requests must arrive within 180 days of the fill. Anything filled before you enrolled does not qualify for reimbursement.

Going to the pharmacy this week? Print the two scripts above and keep them with your current card. If the first price is wrong, you will know exactly which claim order and identifiers to ask the pharmacist to check. → Open the pharmacy counter sheet

---

Why your Rybelsus savings card isn't working

Start with the billing order: the Rybelsus savings card is a secondary claim, so commercial insurance must run first. Other verified failure points include no Rybelsus coverage, missing card identifiers, a pre-card amount above the benefit cap, an ineligible insurance type, a 60- or 90-day 3 mg fill, coupon stacking, or an accumulator or maximizer.

Find your symptom.

Rybelsus savings card rejection decoder

Who to call

Numbers verified against current NovoCare materials on August 3, 2026. Recheck the official page before calling if you are reading this after the displayed verification date.

What people are actually running into

These are short quotes from public forum threads, used to show what's confusing people — not as evidence of what you'll pay, whether you qualify, or how a medication will work for you.

“I was paying $10 … I paid $25.” — r/diabetes_t2

“You have to have prescription coverage and they have to approve it.” — r/RybelsusPill

“They were asking for Rx group and cardholder ID. What are those?” — r/Ozempic

Three different people. Three different failure points. All three are on the table above.

Still stuck after the pharmacy checks the billing order and every field on the card? Call 1-877-304-6855 before you accept a full-price claim. The program administrator can help identify whether the problem is the offer, the eligibility rules, or the benefit cap.

---

Is Rybelsus being discontinued?

Yes. Novo Nordisk told Illinois Medicaid that it will discontinue all strengths of Rybelsus. The Illinois notice says wholesaler shipments would cease beginning in May 2026 and existing inventory was expected to become limited starting in July 2026. Ozempic tablets are the planned transition product, but the switch requires prescriber direction and is not an automatic pharmacy substitution.

This is the single most important fact beyond the savings-card terms.

On May 21, 2026, the Illinois Department of Healthcare and Family Services published a provider notice stating that Novo Nordisk had informed the department it would discontinue all strengths of Rybelsus. The notice gives the transition schedule in plain terms: wholesaler shipments cease beginning in May 2026, with existing inventory expected to become limited starting in July 2026.

Source: Illinois HFS Provider Notice, “Rybelsus Tablets Transition to Ozempic Tablets,” issued May 21, 2026.

What this means for you, practically

• If your pharmacy says Rybelsus is unavailable, the discontinuation may be the reason. Another pharmacy may still have inventory, but the notice describes a product wind-down, not a routine temporary shortage.
• Do not stop or switch on your own. A gap can leave your type 2 diabetes or cardiovascular-risk treatment plan undertreated. Contact the prescriber while you still have medication.
• Expect a new prescription. Illinois Medicaid says its customers will not be automatically converted, and the FDA label says Rybelsus and Ozempic tablets are not substitutable milligram for milligram.
• Coverage work may need to start again. Illinois Medicaid requires a new prior authorization for Ozempic tablets. Other plans set their own rules, so ask your plan whether a new prescription, coverage review, or prior authorization is required.
• The current Rybelsus card remains usable only while Rybelsus is available and every current offer condition is met. A live savings offer does not guarantee that a pharmacy can obtain the medication.

What happens to your savings card?

The same Novo Nordisk Diabetes Savings Offer Program now includes Ozempic tablets under a separate Ozempic offer structure: eligible commercially insured patients with Ozempic tablet coverage may pay as little as $25, subject to the same $100/$200/$300 caps.

One thing the published sources do not answer: whether an existing 48-month Rybelsus activation automatically carries over to Ozempic tablets or whether you need a new Ozempic offer. Call 1-877-304-6855 and ask before the first transition fill.

We'd rather tell you what the published materials do not resolve than guess on something that can decide whether you pay $25 or hundreds more.

---

How do Rybelsus and Ozempic tablet strengths line up?

Rybelsus and Ozempic tablets contain semaglutide, but Ozempic tablets use a better-absorbed formulation and lower milligram strengths. The FDA label pairs Rybelsus 7 mg with Ozempic tablets 4 mg and Rybelsus 14 mg with Ozempic tablets 9 mg after the 30-day initiation phase. Do not switch from Rybelsus 3 mg to Ozempic 1.5 mg during days 1–30, and do not treat the products as milligram-for-milligram substitutes.

Rybelsus-to-Ozempic-tablet transition details and current self-pay prices

Sources: current FDA prescribing information and current Novo Nordisk self-pay terms. Prices and transition details verified August 3, 2026.

⚠ The one safety rule that matters most here

Do not take extra tablets to match your old milligram number.

The new formulation has higher oral bioavailability. The current label estimates that about 0.4% to 1% of a Rybelsus dose reaches systemic circulation, compared with about 1% to 2% for Ozempic tablets. The label also reports no clinically significant difference in mean steady-state exposure between the studied pairs — Rybelsus 3/7/14 mg and Ozempic tablets 1.5/4/9 mg, respectively — but it still prohibits milligram-for-milligram substitution.

A UK medicines regulator issued a medication-error warning during the formulation transition because taking more than one lower-numbered new-formulation tablet to “make up” the old number can cause overdose. That warning is from the UK transition, but the dosing lesson matches the U.S. label: one tablet once daily, and only the prescriber-directed switch.

The current U.S. label sets three rules:

• Do not take more than one tablet per day.
• Do not switch between Rybelsus and Ozempic tablets during days 1–30.
• When switching after initiation, start the other tablet product the day after discontinuing the previous one.

Your prescriber decides the dose. Not the pharmacy, and not a milligram comparison you do at home.

What stays the same

• Same morning routine: take one tablet on an empty stomach with up to 4 ounces of plain water, then wait at least 30 minutes before food, other drinks, or other oral medicines.
• Same approved uses: improving glycemic control in adults with type 2 diabetes and reducing major cardiovascular-event risk in adults with type 2 diabetes who are at high risk. Neither product is approved for chronic weight management.
• Swallow whole. Do not split, crush, chew, or dissolve.

One small detail worth mentioning to your pharmacist or prescriber

The inactive ingredients differ. Rybelsus contains magnesium stearate, microcrystalline cellulose, povidone, and SNAC. Ozempic tablets contain magnesium stearate and SNAC. If you have had a serious reaction to a tablet ingredient, tell the prescriber and pharmacist before the switch.

---

The cheaper path most people miss

Ozempic tablets currently have a manufacturer self-pay price of $199 a month for 4 mg and $299 a month for 9 mg. Because the Rybelsus savings card pays no more than $100 on a one-month fill, there is a pre-card amount at which a prescriber-approved Ozempic tablet maintenance transition costs less than the Rybelsus card result.

We ran the numbers. Here's where the line falls.

Where Ozempic tablet self-pay beats the one-month Rybelsus card estimate

Assumptions: the Rybelsus claim is otherwise eligible for the current one-month card, the card contributes the full $100, the prescriber approves the labeled maintenance transition, and the person qualifies for the current Ozempic tablet self-pay offer. This is a cost comparison, not a recommendation to switch medications.

The arithmetic is easy enough to check yourself. The card estimate leaves you paying your pre-card amount minus up to $100. Cash pay is a flat number. Set them equal and solve.

Worked example, Rybelsus 14 mg: your plan leaves you owing $450. The card pays $100, so you pay $350. Current Ozempic tablet 9 mg self-pay is $299. The separate self-pay path is $51 lower that month — $612 over 12 identical fills — if your prescriber approves the switch and you meet the offer terms.

During a deductible phase, self-pay can win by a much larger margin. If the plan leaves you responsible for $800, the card estimate is $700. The current maintenance-tablet self-pay prices are $199 or $299. But that lower cash amount comes with a real tradeoff.

The honest catch

Ozempic tablet self-pay dollars do not count toward your insurance deductible, out-of-pocket maximum, or Medicare Part D true out-of-pocket spending. Novo Nordisk says the self-pay offer operates entirely outside insurance.

The Rybelsus card runs behind a commercial insurance claim, and Novo Nordisk says it intends the savings to accrue to the patient's out-of-pocket obligations. But a plan's accumulator, maximizer, or other benefit design can change what receives credit.

So if you're likely to hit your out-of-pocket maximum this year anyway — because of another condition, another high-cost medication, or planned care — the higher insurance route may still be the better annual decision. You're buying progress toward the plan limit.

If you're not going to get anywhere near that limit, that argument may be worth nothing to you, and the flat self-pay price may win.

That's the real decision. It's not “is the card good.” It's “which of these two paths do my numbers favor, and does my prescriber approve the transition?”

Not sure which side of the line you're on? You need the amount your plan leaves you owing and your current maintenance strength. Put both into the calculator and it will show the arithmetic and yearly difference. → Compare my savings-card estimate vs. self-pay Ready to verify the cash path directly? The labeled Rybelsus maintenance transitions currently map to Ozempic tablets priced at $199 or $299 per month. The separate $149 price is for Ozempic tablets’ own 1.5 mg initiation dose. NovoCare Pharmacy offers home delivery or local pharmacy pickup options, and you need a prescription written for Ozempic tablets. See current NovoCare Pharmacy self-pay pricing → Official Novo Nordisk link. Not sponsored.

---

If you don't have insurance

The Rybelsus savings card excludes full cash-paying patients, and Rybelsus does not appear on Novo Nordisk's current January 1, 2026 Patient Assistance Program product list. Neither of the two manufacturer paths older articles commonly recommend gives an uninsured reader a current Rybelsus option. Ozempic tablets have a separate self-pay offer: $199 or $299 for the labeled Rybelsus maintenance transitions, while $149 is the price of Ozempic tablets’ own 1.5 mg initiation dose. A prescriber must direct the change.

The correction stale Rybelsus assistance pages miss

Search “Rybelsus without insurance” and you'll still find pages telling you to apply to the Novo Nordisk Patient Assistance Program for free Rybelsus.

We opened Novo Nordisk's current Patient Assistance Program available-products list. The document is dated January 1, 2026 and carries the code NNIPAP_11_01012026.

Rybelsus is not on it.

Ozempic injection is listed for uninsured patients only. Several insulin products and Xultophy are also listed. The official PAP page says products can change and directs applicants to that current list.

If you were about to spend an afternoon gathering documents and chasing your prescriber's office for a Rybelsus PAP application, check the product list first. The current list does not support that path.

Do not turn that into a permanent claim. Programs change. The accurate statement today is:

Rybelsus does not appear on Novo Nordisk's posted January 1, 2026 PAP product list. Recheck the current official list before applying.

Sources: current PAP available-products list and Novo Nordisk Patient Assistance Program.

What does work

Ozempic tablets have a separate self-pay offer through NovoCare Pharmacy. This is not the Rybelsus savings card, and it is not a prescription transfer you can make yourself. A clinician must decide whether Ozempic tablets fit your treatment and write the prescription.

Ozempic tablet self-pay pricing, verified August 3, 2026

NovoCare Pharmacy currently offers home delivery and local pharmacy pickup options. Its current medicine list includes Ozempic tablets and does not list Rybelsus.

Compare that with Rybelsus's current manufacturer list price of $997.58 per package for 3 mg, 7 mg, and 14 mg. List price is not a universal cash price, and retail discount quotes can differ. It is the manufacturer's pre-discount reference price.

You will need a prescription for the new product.

About GoodRx and SingleCare

Discount cards can lower the cash retail price at a specific pharmacy, and it is worth pulling a live quote for your ZIP code before you fill.

But compare that quote against the current manufacturer self-pay prices first. And know that you cannot use a cash-discount card and the Rybelsus manufacturer savings offer on the same fill — the current terms prohibit combining them.

If you're paying out of pocket, price the prescriber-approved transition before your next refill. The current labeled maintenance-transition prices are $199 or $299 per month; $149 is the separate Ozempic tablet initiation-dose price. See current NovoCare Pharmacy pricing → Official link. Not sponsored. Ask your prescriber whether the transition is appropriate before changing products.

---

If you have Medicare, Medicaid, VA, or TRICARE

You cannot use the Rybelsus savings card. Novo Nordisk's current terms exclude people enrolled in Medicare, Medicaid, VA, DoD, TRICARE, and similar federal or state prescription programs. The exclusion still applies when an enrolled person asks to process the Rybelsus prescription as uninsured or self-pay.

That's the bad news, and the published offer does not provide an exception. Here's what you have instead.

Medicare Part D in 2026

• The out-of-pocket cap is $2,100 for covered Part D drugs. Once your qualifying out-of-pocket spending plus certain payments made on your behalf reaches $2,100 in 2026, you pay $0 for covered Part D drugs for the rest of the calendar year. Premiums and noncovered drugs do not become free because of this cap.
• The Medicare Prescription Payment Plan spreads timing, not cost. Every Part D plan offers this option. It can spread out-of-pocket costs across the calendar year, but Medicare says it does not save money or lower the drug's total cost.
• Extra Help can lower covered-drug costs. In 2026, qualifying enrollees pay up to $5.10 for a generic drug and up to $12.65 for a brand-name drug at participating pharmacies; lower limits can apply to some people with Medicaid or QMB status.
• Your plan still controls coverage. Confirm that the prescribed product is on the formulary, whether prior authorization applies, and what the pharmacy will charge before the fill.

Sources: Medicare Part D costs, Extra Help, and Medicare Prescription Payment Plan.

What about the Medicare GLP-1 Bridge?

The Medicare GLP-1 Bridge is a weight-management access program for eligible covered drugs. It is not a Rybelsus savings-card substitute for a type 2 diabetes prescription. Medicare's own tool says people seeking a GLP-1 for conditions their drug plan should cover, including diabetes, should use the plan's coverage process rather than the Bridge.

Can a Medicare beneficiary use Ozempic tablet self-pay instead?

The separate Ozempic tablet self-pay terms allow eligible government-insured people to purchase outside their insurance, but the purchase cannot be submitted for reimbursement or counted toward a deductible, out-of-pocket limit, or Part D true out-of-pocket spending. A prescriber still has to determine whether Ozempic tablets are appropriate and write a new prescription.

That means the choice is not “use the Rybelsus card with Medicare.” You cannot. The real comparison is:

1. Use the Medicare plan for a covered diabetes treatment and receive Part D protections; or
2. Pay entirely outside the plan under a separate eligible self-pay offer, knowing none of that spending counts toward Part D.

Medicaid, TRICARE, and VA

Coverage and prior-authorization rules vary by state and program. Check the current formulary and ask the program what it requires for the prescribed diabetes treatment.

Illinois Medicaid has published a specific Rybelsus-to-Ozempic-tablet transition: it requires a new prescription and a new prior authorization for Ozempic tablets. Do not assume that one state's notice describes every Medicaid, VA, or TRICARE plan.

Related: What GLP-1 does TRICARE cover? · Best GLP-1 for seniors

On Medicare and not sure where to start? Open Medicare Plan Finder, confirm whether the prescribed diabetes treatment is on your plan's current formulary, and ask whether a new prescription or prior authorization is required before your Rybelsus supply runs out. Take the free Find My GLP-1 Path quiz for situation-specific next steps →

---

Can you use the Rybelsus savings card for a 90-day supply?

Potentially, but only for the 7 mg or 14 mg strengths, and only when the prescription is written and dispensed for 90 days and your commercial plan covers a 90-day fill. Rybelsus 3 mg is limited to one 30-day prescription per redemption under the current terms.

Rybelsus savings card by strength and days supply

Every “potentially eligible” cell still depends on commercial coverage and every other offer rule.

Is a 90-day fill $25 total or $25 per month? The offer says an eligible person may pay as little as $25 for the three-month prescription — total, not monthly — subject to the $300 maximum benefit. If the plan leaves you owing more than $325 for the 90 days, you'll pay more than $25.

Quick math on a 90-day fill: owe $325, estimated payment $25. Owe $350, estimated payment $50. Owe $500, estimated payment $200.

Why is 3 mg limited to 30 days? The current FDA label identifies 3 mg as the recommended Rybelsus initiation dose for days 1–30, says it is not effective for glycemic control, and uses the lower initiation dose to reduce the risk of gastrointestinal adverse reactions. The clinician controls what happens after day 30.

If you're on a maintenance dose, ask the prescriber and insurer whether a 90-day prescription is appropriate and covered. Fewer pharmacy trips can help, but the plan has to cover the multi-month claim for the larger cap to apply.

---

Can you stack the Rybelsus savings card with GoodRx or SingleCare?

No. Novo Nordisk's current terms prohibit combining the Rybelsus savings card with another coupon, voucher, certificate, self-pay discount, or cash-discount card. The stated exception is a manufacturer-sponsored automatic eVoucher at a participating pharmacy. Ask the pharmacy to price each path separately and use whichever final price is lower.

These are two completely different payment paths.

Manufacturer savings offer vs. pharmacy discount card

Ask the pharmacist for two quotes: “What's my final price with my insurance and the manufacturer offer, and what's my separate cash price with this discount card?” Then pick one. Do not ask them to combine the two — the current terms prohibit it.

---

“I'm taking this for weight loss” — the honest reroute

Rybelsus is FDA-approved for type 2 diabetes and for reducing major cardiovascular-event risk in adults who have type 2 diabetes and are at high risk. It is not approved for chronic weight management. The Rybelsus savings card can apply only when an eligible commercial plan covers the Rybelsus claim, regardless of why it was prescribed.

We'd rather cost ourselves a click than let you waste two weeks on the wrong cost path.

If weight management is your actual goal, you may be chasing the wrong card. Not because Rybelsus “does nothing,” but because its current label is the type 2 diabetes lane and the card requires the commercial plan to cover the claim. If the plan rejects the claim, there is no covered cost sharing for this card to reduce.

There is now an oral semaglutide product approved specifically for chronic weight management. Wegovy tablets reach a 25 mg daily maintenance dose, and the current manufacturer self-pay offer starts at $149/month for the 1.5 mg initiation dose. Standard self-pay pricing is $299/month for the 9 mg and 25 mg doses; a temporary 4 mg offer is $149 through August 31, 2026, then the standard 4 mg price is $199.

Oral semaglutide options, by what they're approved for

If you want to know whether insurance covers an FDA-approved weight-management option

Before you book a program, find out which treatment paths your plan covers. That answer can change whether the best next move is insurance, a manufacturer self-pay program, or a different medication.

Ro offers FDA-approved weight-management options including Wegovy tablets, Wegovy pen, Zepbound, and Foundayo. Its free GLP-1 Insurance Coverage Checker currently checks Ozempic pen, Wegovy pen, and Zepbound pen. Ro says it cannot currently check insurance coverage for the Wegovy pill, Foundayo pill, or Zepbound KwikPen through that free tool.

If you join Ro Body and pursue one of the insurance-supported injectable options, the membership includes an insurance concierge that can check coverage, handle prior-authorization paperwork, communicate with the insurer, and appeal a denial. Coverage is not guaranteed. Ro Body is $39 for the first month, then $149/month on the monthly plan or as low as $74/month with a 12-month plan paid upfront. Medication is separate.

Does that sound like your situation? If weight management is the goal and you want a free coverage report for the injectable options Ro currently checks: Check GLP-1 pen coverage with Ro — free coverage report → (sponsored affiliate link, opens in a new tab) Want an oral option or not sure which treatment path fits your insurance, state, and budget? Take the free Find My GLP-1 Path quiz →

---

⚠ Before you chase the savings

Rybelsus and Ozempic tablets are prescription medications, and price should never be the only thing that decides whether you take one.

Do not use either if you or a family member has had medullary thyroid carcinoma (MTC), if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or if you have had a serious hypersensitivity reaction to semaglutide or an ingredient in the product. Talk to a clinician about pancreatitis, diabetic-retinopathy history or vision changes, severe stomach problems, dehydration and kidney risk, gallbladder symptoms, low blood sugar if you also take insulin or a sulfonylurea, pregnancy plans, breastfeeding, and any upcoming surgery or procedure involving anesthesia or deep sedation.

The label says to discontinue Rybelsus or Ozempic tablets at least two months before a planned pregnancy and says breastfeeding is not recommended during treatment with either tablet product.

Full details are in the official prescribing information and Medication Guide.

The cardiovascular benefit is real, but it is not a reason to self-switch or stretch a supply. In the SOUL cardiovascular outcomes trial, 9,650 adults were randomized. A major adverse cardiovascular event occurred in 579 of 4,825 people (12.0%) assigned to semaglutide tablets 14 mg and 668 of 4,825 (13.8%) assigned to placebo, producing a hazard ratio of 0.86 (95% CI 0.77–0.96). That trial result supports the labeled cardiovascular indication; it does not predict one person's outcome. Solve the cost and transition problem with the prescriber instead of stopping or changing the dose on your own.

---

What we actually verified for this guide

We checked the current savings offer, generated-card terms, pharmacy instructions, patient-assistance product list, manufacturer self-pay prices, FDA labeling, the Rybelsus discontinuation notice, and current Medicare rules on August 3, 2026. The cost tables and break-even points on this page are The RX Index's calculations from those source terms — not results from a test insurance claim or a medication purchase.

The distinction matters here. A marketing page can tell you “as little as $25” and still leave out the $100 cap that decides your actual bill. A transition notice can tell a state Medicaid program what to do and still not prove that every commercial plan uses the same prior-authorization rule. We separated those claims instead of blending them.

Source verification log

What we did not do

• We did not buy Rybelsus or Ozempic tablets.
• We did not submit an insurance claim or ask a pharmacy to run a test claim.
• We did not test whether one person's insurer credits manufacturer assistance toward a deductible.
• We are not the program administrator and have no relationship with Novo Nordisk.
• No one on our team is claiming personal treatment experience with Rybelsus or Ozempic tablets.

What the published sources still do not resolve

Does an existing 48-month Rybelsus savings activation carry over to Ozempic tablets? The current public materials do not say. Call 1-877-304-6855 before the first Ozempic tablet fill and ask whether a separate enrollment is required.

What gets rechecked — and when

Why this page exists

Novo Nordisk's pages tell you where to get the Rybelsus savings card. They do not calculate what the $100 cap leaves you paying, compare that result with the manufacturer's separate Ozempic tablet self-pay offer, reconcile the official $10/$25 conflict, or connect a pharmacy rejection with the Rybelsus wind-down.

We put those decisions in one place. If something here is wrong or a source changes, report it through The RX Index corrections page.

---

Rybelsus savings card frequently asked questions

The current Rybelsus savings card can reduce an eligible commercially insured fill toward $25, but the $100-per-month cap, plan coverage, days supply, insurance type, and pharmacy processing decide the result. These answers close the remaining questions most likely to send someone back to search.

How much is Rybelsus with the savings card?

For a one-month eligible fill, the estimate is the amount left after commercial insurance minus up to $100, with a $25 floor unless the insurance-processed amount was already lower. If the plan leaves $125 or less, the card can bring the amount to $25. If the plan leaves $300, the estimate is $200.

Who qualifies for the Rybelsus savings card?

A person may qualify when they have a valid Rybelsus prescription, live in the United States or a U.S. territory, have eligible commercial or private insurance, have Rybelsus coverage under that plan, process the claim through that plan, and meet every other current term. Medicare, Medicaid, VA, DoD, TRICARE, certain government-subsidized retiree plans, uninsured patients, and people processing outside insurance are excluded.

Do ACA Marketplace, FEHB, and state employee plans qualify?

The current terms say those three plan categories are not treated as federal or state government health programs for this offer. That removes one exclusion; it does not guarantee eligibility. Rybelsus still has to be covered and every other rule still applies.

Can Medicare patients use the Rybelsus savings card?

No. The current terms exclude Medicare and other named government prescription programs, even when the person asks to process the Rybelsus fill as self-pay. Use the Part D formulary and coverage process for a diabetes prescription, or compare a separate outside-insurance self-pay offer without treating it as a savings-card claim.

Why did my Rybelsus savings card stop covering as much?

The terms changed effective January 2, 2026. The maximum benefit for a one-month fill dropped from $300 to $100, and the advertised floor changed from $10 to $25. On an unchanged $400 pre-card amount, that moves the estimated payment from $100 to $300.

Is the Rybelsus savings card $10 or $25?

Use $25 under the current dated terms. An official Rybelsus Resources page still displays $10, but the active offer, current card output, and January 2026 terms state $25.

Is the $25 amount guaranteed?

No. “As little as $25” is a conditional floor. The card can contribute no more than $100 for 30 days, $200 for 60 days, or $300 for 90 days, so a larger pre-card responsibility can leave you paying more than $25.

How long is the Rybelsus savings card valid?

The current terms say activation is valid for up to 48 months from enrollment. That does not freeze the benefit: Novo Nordisk reserves the right to change or end the offer, so recheck the current terms before relying on an old card.

Does the Rybelsus savings card work at CVS or Walgreens?

It may be redeemed at participating retail pharmacies. The public terms do not guarantee that every location in a chain participates or processes the claim correctly. Bring the current card, have commercial insurance run first, and use the pharmacist help desk at 1-844-373-0987 if the secondary claim fails.

What are the Rybelsus savings card BIN and PCN?

The current generated offer uses BIN 019158 and PCN CNRX. The pharmacy also needs the group and member IDs shown on the card generated for you, plus the correct secondary-claim setup. Do not copy another person's group or member ID.

Can I use GoodRx or SingleCare with the Rybelsus savings card?

No. The current terms prohibit combining the offer with another coupon, voucher, certificate, self-pay discount, or cash-discount card. A manufacturer-sponsored automatic eVoucher at a participating pharmacy is the stated exception. Ask for separate final-price quotes and choose one path.

Can I use the card for a 90-day supply?

Potentially for Rybelsus 7 mg or 14 mg when the prescription is written and dispensed for 90 days and the commercial plan covers a 90-day fill. Rybelsus 3 mg is limited to a 30-day prescription per redemption.

Is there a Rybelsus coupon if I do not have insurance?

The manufacturer savings card excludes full cash-paying patients. Rybelsus also does not appear on Novo Nordisk's current January 1, 2026 PAP product list, and NovoCare does not currently list a manufacturer self-pay offer for Rybelsus. Check a live pharmacy cash-discount quote and ask the prescriber whether the separate Ozempic tablet self-pay path is appropriate.

Is Rybelsus being discontinued?

Yes. Novo Nordisk told Illinois HFS it would discontinue all Rybelsus strengths. The May 21, 2026 notice says shipments to wholesalers would cease beginning in May and existing inventory was expected to become limited starting in July.

Can I still use the Rybelsus card while pharmacies have inventory?

The offer remains published and can apply only if the medication is available, the commercial plan covers the claim, and every current term is met. A live card does not guarantee that a pharmacy can obtain Rybelsus during the wind-down.

Is the Ozempic pill the same as Rybelsus?

Both tablet products contain semaglutide, but Ozempic tablets use a better-absorbed formulation with different strengths. The FDA label says they are not substitutable milligram for milligram.

Will my dose change when I switch to Ozempic tablets?

The labeled maintenance pairs are Rybelsus 7 mg to Ozempic tablets 4 mg and Rybelsus 14 mg to Ozempic tablets 9 mg. Do not switch during days 1–30, and do not make a 3 mg-to-1.5 mg conversion yourself. The prescriber directs the transition.

Do I need a new prescription for Ozempic tablets?

Yes for the Illinois Medicaid transition, and the products are not automatic milligram-for-milligram substitutes. Ask the prescriber to write the Ozempic tablet prescription and ask the insurer whether a new coverage review or prior authorization applies to your plan.

How much does Rybelsus cost without insurance?

Novo Nordisk currently lists Rybelsus at $997.58 per package for all three strengths. That is a manufacturer list price, not a guaranteed pharmacy cash price. Rybelsus has no current NovoCare manufacturer self-pay offer listed; Ozempic tablets have a separate $149/$199/$299 monthly self-pay structure.

Does the Rybelsus savings card work for weight loss?

The card can apply only when an eligible commercial plan covers the Rybelsus claim and every term is met. Rybelsus is not FDA-approved for chronic weight management. Wegovy tablets are the oral semaglutide product approved for the weight-management lane.

Does my existing Rybelsus card transfer to Ozempic tablets?

The current published materials do not answer that question. Call 1-877-304-6855 and ask whether you need a separate Ozempic offer before the first transition fill.

---

Still not sure which GLP-1 program is right for you?

Take our free 60-second matching quiz. Tell us your insurance, your goal, your preferred treatment path, and your budget — we'll point you to the path that fits, whether that is a manufacturer savings card, an insurance route, a self-pay program, or a different medication discussion with your prescriber.

🎯 Take the free Find My GLP-1 Path quiz →

---

Related guides on The RX Index

• Best GLP-1 for Diabetes: Blood Sugar, Heart & Cost
• Best GLP-1 for Seniors: Safety, Cost & Medicare (2026)
• What GLP-1 Does TRICARE Cover in 2026?
• How Commercial-Insurance GLP-1 Copay Cards Work

---

Sources and disclosures

Primary sources

• NovoCare Diabetes Savings Offer Program eligibility and terms
• Current printable Rybelsus Savings Offer
• Rybelsus Savings & Support
• Rybelsus Resources page
• Novo Nordisk Patient Assistance Program
• Novo Nordisk PAP Available Products list, dated Jan. 1, 2026
• NovoCare Pharmacy
• NovoCare Rybelsus list price
• FDA prescribing information and Medication Guide for Rybelsus and Ozempic tablets
• UK MHRA Drug Safety Update: Rybelsus transition to a new formulation and risk of medication error, Dec. 17, 2025
• Illinois HFS: Rybelsus Tablets Transition to Ozempic Tablets, May 21, 2026
• Medicare.gov: Part D drug coverage costs
• Medicare.gov: Extra Help
• Medicare Prescription Payment Plan
• Medicare GLP-1 weight-loss-drug coverage
• Official Wegovy indications
• Official Wegovy savings and self-pay terms
• Ro GLP-1 Insurance Coverage Checker
• Ro Body pricing

Medical disclaimer: This page is informational and educational, not medical advice. Rybelsus, Ozempic tablets, and Wegovy tablets are prescription medications. A licensed healthcare professional must decide whether a medication is appropriate and direct any start, stop, dose change, or product transition. Report suspected adverse reactions to the FDA through MedWatch or at 1-800-FDA-1088.

About The RX Index: Independent guidance for choosing your GLP-1 path. We score providers and treatment paths on what actually matters — clinical legitimacy, care quality, transparency, access, and cost — then help you decide where to start.

Last verified: August 3, 2026 · Next scheduled re-verification: August 31, 2026